• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛛网膜下腔出血后的病死率和功能转归:一项系统评价

Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review.

作者信息

Hop J W, Rinkel G J, Algra A, van Gijn J

机构信息

University Department of Neurology, Utrecht, Netherlands.

出版信息

Stroke. 1997 Mar;28(3):660-4. doi: 10.1161/01.str.28.3.660.

DOI:10.1161/01.str.28.3.660
PMID:9056628
Abstract

BACKGROUND

During the last three decades, new management strategies have been developed for patients with aneurysmal subarachnoid hemorrhage. To assess whether the case-fatality rate has improved after the introduction of new management strategies, we studied outcome in all population-based studies from 1960 onward.

SUMMARY OF REVIEW

To identify population-based studies that reported on case-fatality rate in subarachnoid hemorrhage, we performed a MEDLINE search and checked all reference lists of the studies found. Two authors (J.W.H. and G.J.E.R.) independently assessed all studies for eligibility, using predefined criteria for case finding and diagnosis, and extracted data on case-fatality rates. We used weighted linear regression analysis to quantify change in case-fatality rate over time. We found 21 studies, describing 25 study periods between 1960 and 1992. Case-fatality rates varied between 32% and 67%, with the exception of one recent study. The case-fatality rate decreased by 0.5% per year (95% confidence interval, -0.1 to 1.2); the decline was steeper after adjustment for age and sex (0.9% per year; 95% confidence interval, -0.7 to 2.6; data from 12 studies).

CONCLUSIONS

The case-fatality rate after subarachnoid hemorrhage has decreased during the last three decades. A plausible explanation for this decrease is the improved management of patients with subarachnoid hemorrhage.

摘要

背景

在过去三十年中,已为动脉瘤性蛛网膜下腔出血患者制定了新的管理策略。为了评估新管理策略引入后病死率是否有所改善,我们研究了1960年以来所有基于人群的研究结果。

综述总结

为了确定报告蛛网膜下腔出血病死率的基于人群的研究,我们进行了MEDLINE检索,并检查了所发现研究的所有参考文献列表。两位作者(J.W.H.和G.J.E.R.)使用预先定义的病例发现和诊断标准,独立评估所有研究的合格性,并提取病死率数据。我们使用加权线性回归分析来量化病死率随时间的变化。我们发现了21项研究,描述了1960年至1992年之间的25个研究时期。除一项近期研究外,病死率在32%至67%之间。病死率每年下降0.5%(95%置信区间,-0.1至1.2);在对年龄和性别进行调整后,下降更为明显(每年0.9%;95%置信区间,-0.7至2.6;来自12项研究的数据)。

结论

在过去三十年中,蛛网膜下腔出血后的病死率有所下降。这种下降的一个合理原因是蛛网膜下腔出血患者管理的改善。

相似文献

1
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review.蛛网膜下腔出血后的病死率和功能转归:一项系统评价
Stroke. 1997 Mar;28(3):660-4. doi: 10.1161/01.str.28.3.660.
2
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis.根据年龄、性别和地区,动脉瘤性蛛网膜下腔出血的病死率随时间的变化:一项荟萃分析。
Lancet Neurol. 2009 Jul;8(7):635-42. doi: 10.1016/S1474-4422(09)70126-7. Epub 2009 Jun 6.
3
Case fatality and functional outcome after spontaneous subarachnoid haemorrhage: A systematic review and meta-analysis of time trends and regional variations in population-based studies.自发性蛛网膜下腔出血后病死率和功能结局:基于人群的研究中时间趋势和地域差异的系统评价和荟萃分析。
Eur Stroke J. 2024 Sep;9(3):555-565. doi: 10.1177/23969873241232823. Epub 2024 Feb 14.
4
Hospital case-volume is associated with case-fatality after aneurysmal subarachnoid hemorrhage.医院病例量与动脉瘤性蛛网膜下腔出血后的病死率相关。
Int J Stroke. 2019 Apr;14(3):282-289. doi: 10.1177/1747493018790073. Epub 2018 Jul 18.
5
Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review.蛛网膜下腔出血结局的时间趋势:基于人群的研究和系统评价。
Neurology. 2010 May 11;74(19):1494-501. doi: 10.1212/WNL.0b013e3181dd42b3. Epub 2010 Apr 7.
6
Has there been a decline in subarachnoid hemorrhage mortality?蛛网膜下腔出血的死亡率是否有所下降?
Stroke. 1989 Jun;20(6):718-24. doi: 10.1161/01.str.20.6.718.
7
Outcome After Clipping and Coiling for Aneurysmal Subarachnoid Hemorrhage in Clinical Practice in Europe, USA, and Australia.欧洲、美国和澳大利亚临床实践中动脉瘤性蛛网膜下腔出血的夹闭与血管内治疗的结果。
Neurosurgery. 2019 May 1;84(5):1019-1027. doi: 10.1093/neuros/nyy223.
8
Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998.1980 - 1989年与1990 - 1998年间日本出云市动脉瘤性蛛网膜下腔出血的发病率和病死率趋势
Stroke. 2001 Jul;32(7):1499-507. doi: 10.1161/01.str.32.7.1499.
9
Computed tomography angiography spot sign does not predict case fatality in aneurysmal subarachnoid hemorrhage with intraparenchymal extension.计算机断层血管造影斑点征不能预测伴有脑实质内扩展的动脉瘤性蛛网膜下腔出血的病死率。
Stroke. 2013 Jun;44(6):1590-4. doi: 10.1161/STROKEAHA.111.000586. Epub 2013 Apr 9.
10
Case Fatality Rates of Subarachnoid Hemorrhage Are Decreasing with Substantial between-Country Variation: A Systematic Review of Population-Based Studies between 1980 and 2020.蛛网膜下腔出血的病死率呈下降趋势,但国家间差异较大:1980 年至 2020 年期间基于人群的研究的系统评价。
Neuroepidemiology. 2022;56(6):402-412. doi: 10.1159/000526983. Epub 2022 Oct 25.

引用本文的文献

1
The Discriminative Ability of ROTEM for Delayed Cerebral Ischemia and Poor Outcome Following Aneurysmal Subarachnoid Hemorrhage.旋转血栓弹力图(ROTEM)对动脉瘤性蛛网膜下腔出血后迟发性脑缺血及不良预后的鉴别能力
Neurocrit Care. 2025 Jul 16. doi: 10.1007/s12028-025-02309-x.
2
Dose-response and infusion duration of intra-arterial nimodipine in cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a single-center case series.动脉瘤性蛛网膜下腔出血后脑血管痉挛患者动脉内注射尼莫地平的剂量反应及输注持续时间:一项单中心病例系列研究
Neuroradiology. 2025 Jul 16. doi: 10.1007/s00234-025-03699-7.
3
Automatic diagnosis and measurement of intracranial aneurysms using deep learning in MRA raw images.
利用深度学习在MRA原始图像中自动诊断和测量颅内动脉瘤
Front Neurol. 2025 Apr 24;16:1544571. doi: 10.3389/fneur.2025.1544571. eCollection 2025.
4
Predicting early functional outcomes in aneurysmal subarachnoid hemorrhage in endovascular coiling and surgical clipping.预测血管内栓塞和外科夹闭治疗的动脉瘤性蛛网膜下腔出血的早期功能结局
Front Neurol. 2025 May 7;16:1466188. doi: 10.3389/fneur.2025.1466188. eCollection 2025.
5
Dissecting the Genetic Architecture of Intracranial Aneurysms.剖析颅内动脉瘤的遗传结构
Circ Genom Precis Med. 2025 Jun;18(3):e004626. doi: 10.1161/CIRCGEN.123.004626. Epub 2025 Apr 21.
6
Fast simulation of hemodynamics in intracranial aneurysms for clinical use.用于临床的颅内动脉瘤血流动力学快速模拟。
Acta Neurochir (Wien). 2025 Mar 3;167(1):56. doi: 10.1007/s00701-025-06469-9.
7
Association Between Neurological Outcomes and Timing of Physical Therapy Initiation Among Patients Treated for Aneurysmal Subarachnoid Hemorrhage: A Propensity-Adjusted Analysis.动脉瘤性蛛网膜下腔出血患者神经功能结局与物理治疗开始时间的关联:一项倾向调整分析
Neurosurg Pract. 2023 Jun 21;4(3):e00046. doi: 10.1227/neuprac.0000000000000046. eCollection 2023 Sep.
8
Effectiveness of human albumin for clinical outcome in aneurysmal subarachnoid hemorrhages: a protocol for randomized controlled (HASH) trial.人血白蛋白对动脉瘤性蛛网膜下腔出血临床结局的有效性:一项随机对照(HASH)试验方案
Trials. 2025 Feb 14;26(1):53. doi: 10.1186/s13063-025-08762-5.
9
Predicting prognosis using stroke-heart indicator: brain natriuretic peptide in patients with aneurysmal subarachnoid hemorrhage.使用卒中-心脏指标预测预后:脑钠肽在动脉瘤性蛛网膜下腔出血患者中的应用
Front Neurol. 2025 Jan 22;16:1510235. doi: 10.3389/fneur.2025.1510235. eCollection 2025.
10
Analysis of delayed cerebral ischemia incidence after treatment for aneurysmal subarachnoid hemorrhage in young adults: A cohort study.青年成人动脉瘤性蛛网膜下腔出血治疗后迟发性脑缺血发生率的分析:一项队列研究
Surg Neurol Int. 2024 Dec 6;15:449. doi: 10.25259/SNI_648_2024. eCollection 2024.